Impact News +++ Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call... (Business Wire) +++ SENSUS HEALTHCARE Aktie +3,91%

KENVUE Aktie

>KENVUE Aktienkurs

19.18 EUR +0.2% (Tradegate)

Ask: 19.248 EUR / 200 Stück

Bid: 19.05 EUR / 200 Stück

Tagesumsatz: 4836 Stück

Realtime Kurs von 8 bis 22 Uhr!

KENVUE Aktie über LYNX handeln

Intraday

1 Jahr

>KENVUE Performance

1 Woche: +2,7%

1 Monat: +4,1%

3 Monate: -4,8%

6 Monate: -3,4%

1 Jahr: +15,7%

laufendes Jahr: -6,3%

>KENVUE Aktie

Name:

KENVUE INC. DL -,001

Land:

USA

Sektor:

Konsumgueter / Gastronomie

ISIN/ Wkn:

US49177J1025 / A3EEHU

Symbol/ Ticker:

J4D (Frankfurt) / KVUE (NYSE)

Kürzel:

FRA:J4D, ETR:J4D, J4D:GR, NYSE:KVUE

Index:

Webseite:

https://www.kenvue.com/

Marktkapitalisierung:

36963.99 Mio. EUR

Umsatz:

12996.4 Mio. EUR

EBITDA:

2738.05 Mio. EUR

Gewinn je Aktie:

0.47 EUR

Schulden:

7516.9 Mio. EUR

Liquide Mittel:

897.68 Mio. EUR

Umsatz-/ Gewinnwachstum:

-1.44% / -29.36%

KGV/ KGV lG:

38.45 / 20.26

KUV/ KBV/ PEG:

2.85 / 4.03 / 1.03

Gewinnm./ Eigenkapitalr.:

6.9% / 10.22%

Dividende je Aktie:

0.76 EUR

Dividendenrendite/ -schätzung:

4% / 3.62%

Div. Historie:

14.05.25 - 0.18324€
12.02.25 - 0.19787€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

KENVUE

Letzte Datenerhebung:

24.07.25

>KENVUE Eigentümer

Aktien: 1919.91 Mio. St.

f.h. Aktien: 1920 Mio. St.

Insider Eigner: 0.04%

Instit. Eigner: 101.17%

Leerverk. Aktien: 1.53%

>KENVUE Peer Group

BROWN-FORMAN B

BROWN-FORMAN A

CAMPBELLS

COTY

CRACKER BARREL

DARDEN RESTAURANTS

HERMES INTERNATIONAL ADR

POST HOLDINGS

SCOTTS MIRACLE-GRO

VITA COCO

>KENVUE Chart & Kurs - NYSE

>KENVUE News

16.07.25 - 19:36	Kenvue Stock Has Unusual Put Option Activity After Lower Q2 Sales and CEO Firing (Barchart)
	Kenvue, which manufactures Band-Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO had left. Put options are showing unusually......

16.07.25 - 13:42	Kenvues Q2 2025 Earnings: What to Expect (Barchart)
	Kenvue is expected to release its second-quarter earnings next month, and analysts anticipate a double-digit profit dip....

14.07.25 - 22:48	Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here? (Barchart)
	Kenvue Inc ousted its chief executive and announced a strategic review on Monday. Jefferies says KVUE shares could rally to $27....

14.07.25 - 17:15	Market Voices: White House vs. Powell, EU tariffs, Kenvue′s new CEO (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.07.25 - 16:39	Kenvue: Neutrogena-Hersteller feuert CEO und prüft Strategiewechsel (Handelsblatt)
	Für Marken wie Listerine und Neutrogena ist der Konsumgüterhersteller bekannt. Operativ hat das Unternehmen allerdings mit Probleme zu kämpfen....

14.07.25 - 14:42	Autodesk, Fastenal and Kenvue rise premarket; CrowdStrike falls (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

14.07.25 - 14:42	Kenvue CEO Mongon leaves the consumer health company as it continues its strategic review (AP)
	Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic review of the company...

14.07.25 - 14:18	Stocks making the biggest moves premarket: Kenvue, Rivian, Affirm, SolarEdge Technologies and more (CNBC)
	These are some of the stocks posting the largest moves in premarket trading....

14.07.25 - 14:09	Kenvue CEO Mongon stepping down as company continues with strategic review (AP)
	Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company...

14.07.25 - 13:54	Kenvue Appoints Kirk Perry As Interim CEO After Thibaut Mongon Departs (AFX)
	WASHINGTON (dpa-AFX) - Consumer health company Kenvue, Inc. (KVUE) announced Monday that its Board of Directors has appointed Kirk Perry as Interim Chief Executive Officer, effective immediately. ......

14.07.25 - 13:18	Kenvue CEO steps down amid boards strategic review (CNBC)
	Tylenol maker Kenvue's CEO and board member Thibaut Mongon has stepped down, it said on Monday and named company director Kirk Perry as interim chief executive....

14.07.25 - 13:15	Kenvue CEO steps down amid board′s strategic review (Reuters EN)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

14.07.25 - 13:12	Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.07.25 - 12:51

Kenvue Announces CEO Transition and Actions to Unlock Shareholder Value (Business Wire)

Appoints Current Kenvue Director and Proven CPG and Technology Company Leader, Kirk Perry, as Interim CEO, Effective Immediately Announces Ongoing Review of Strategic Alternatives Reports Select Preliminary Second Quarter 2025 Financial Results SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company to unlock shareholder value and reach its full potential. The Board has made a Chief Executive Officer transition and is advancing an ongoing comprehensive review of strategic alternatives. “Kenvue has world-class brands in attractive categories and a strong global platform. The actions announced today are to ensure we have the right talent, brand portfolio and operational foundation to fully capitalize on those strengths, accelerate profitable growth and best position the Company for future success,” said Larry Merlo, Kenvue's Chair of the Board. “The Board's strategic review is underway, and we are cons...

26.06.25 - 12:42	Kenvue Releases Second Annual Healthy Lives Mission Report Highlighting Progress in Reducing Emissions and Advancing More Sustainable Product Innovation (Accesswire)
	Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio NORTHAMPTON, MA / ACCESS Newswi......

16.06.25 - 20:00	Kenvue takeover speculation heats up ahead of M&A window (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

13.06.25 - 00:48	Kenvue Is Considering Selling Some Brands, Reuters Reports (Bloomberg)
	Kenvue Inc., the consumer-health business that was part of Johnson & Johnson, is exploring a sale of some of its skin-care and beauty brands, Reuters reported Thursday, citing people familiar with the matter....

13.06.25 - 00:27	Kenvue considering selling some skin, beauty brands - report (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.06.25 - 09:00	Is Kenvue Stock Outperforming the Nasdaq? (Barchart)
	Despite its recent underperformance, Kenvue has outpaced the Nasdaq over the past year, and analysts remain moderately bullish on the stock's prospects....

04.06.25 - 16:03	Buy the dip in Kenvue stock: Jefferies (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Im strengen Sinne des Wortes hat es nie eine wirkliche Demokratie gegeben und wird es niemals geben. - Jean-Jacques Rousseau

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram